NO933918D0 - 2- og 5-alkyl- og fenylsubstituerte 4-(1-hydroksy-, 1-acyloksy- eller 1-karbamoyloksy)-5-hydroksy-2(5h)-furanoner som anti-inflammatoriske midler - Google Patents
2- og 5-alkyl- og fenylsubstituerte 4-(1-hydroksy-, 1-acyloksy- eller 1-karbamoyloksy)-5-hydroksy-2(5h)-furanoner som anti-inflammatoriske midlerInfo
- Publication number
- NO933918D0 NO933918D0 NO1993933918A NO933918A NO933918D0 NO 933918 D0 NO933918 D0 NO 933918D0 NO 1993933918 A NO1993933918 A NO 1993933918A NO 933918 A NO933918 A NO 933918A NO 933918 D0 NO933918 D0 NO 933918D0
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- phenyl
- hydroxy
- substituted phenyl
- carbons
- Prior art date
Links
- 229940121363 anti-inflammatory agent Drugs 0.000 title 1
- 239000002260 anti-inflammatory agent Substances 0.000 title 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 15
- 125000000217 alkyl group Chemical group 0.000 abstract 6
- 229910052736 halogen Inorganic materials 0.000 abstract 6
- 125000005843 halogen group Chemical group 0.000 abstract 6
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 5
- 125000001624 naphthyl group Chemical group 0.000 abstract 3
- 125000003837 (C1-C20) alkyl group Chemical group 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- RHDGNLCLDBVESU-UHFFFAOYSA-N but-3-en-4-olide Chemical group O=C1CC=CO1 RHDGNLCLDBVESU-UHFFFAOYSA-N 0.000 abstract 1
- 150000002241 furanones Chemical class 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/60—Two oxygen atoms, e.g. succinic anhydride
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
- C07F7/0814—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring said ring is substituted at a C ring atom by Si
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Rheumatology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/693,204 US5183906A (en) | 1991-04-30 | 1991-04-30 | 2- and 5-alkyl and phenyl substituted 4-(1-hydroxy, 1-acyloxy or 1-carbamoyloxy)-5-hydroxy-2 (5h)-furanones as anti-inflammatory agents |
| PCT/US1992/003623 WO1992019610A1 (en) | 1991-04-30 | 1992-04-29 | 2- and 5-alkyl and phenyl substituted 4-(1-hydroxy, 1-acyloxy or 1-carbamoyloxy)-5-hydroxy-2(5h)-furanones as anti-inflammatory agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO933918D0 true NO933918D0 (no) | 1993-10-29 |
| NO933918L NO933918L (no) | 1993-12-28 |
Family
ID=24783742
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO933918A NO933918L (no) | 1991-04-30 | 1993-10-29 | 2- og 5-alkyl-og fenylsubstituerte 4- (1-hydroksy-, 1-acyloksy- e ller 1- karbamoyloksy)-5-hydroksy-2(5H)- furanoner som anti-inflammatorisk e midler |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5183906A (no) |
| EP (1) | EP0579769B1 (no) |
| JP (1) | JP3181054B2 (no) |
| AT (1) | ATE172459T1 (no) |
| AU (1) | AU1923892A (no) |
| CA (1) | CA2109064A1 (no) |
| DE (1) | DE69227366T2 (no) |
| ES (1) | ES2124261T3 (no) |
| NO (1) | NO933918L (no) |
| WO (1) | WO1992019610A1 (no) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5268387A (en) * | 1992-04-24 | 1993-12-07 | Allergan, Inc. | Pharmaceutical compositions and method for administering 3 and 4-substituted 2(5H)-furanones to a mammal for inhibiting bone loss |
| WO1994026279A1 (en) * | 1993-05-18 | 1994-11-24 | The Upjohn Company | Bisphosphonate esters for treating gastric disorders |
| KR960703901A (ko) * | 1993-08-19 | 1996-08-31 | 로즈 암스트롱 | 치환된 2(5H)푸라논, 2(5H)티오페논 및 2(5H)피롤론 유도체, 그의 제조 방법 및 엔도텔린 길항제로서의 그의 용도(Substituted 2(5H)Furanone, 2(5H)Thiophenone and 2(5H)Pyrrolone Derivatives, Their Preparation and Their Use as Endothelin antagonists) |
| US5464865A (en) * | 1993-12-22 | 1995-11-07 | Ortho Pharmaceutical Corporation | 4-aryl- and 4-arylthio-5-hydroxy-2(5H)-furanones as inhibitors of phospholipase A2 |
| US5451686A (en) * | 1994-04-15 | 1995-09-19 | Allergan, Inc. | 3 and 5 alkyl and phenyl 4-(hydroxy or acyloxy)-alkyl substituted 2(5H)-furanones as anti-inflammatory agents |
| US5639468A (en) * | 1995-06-07 | 1997-06-17 | University Of Southern California | Method for reducing or preventing post-surgical adhesion formation using manoalide and analogs thereof |
| US5922759A (en) * | 1996-06-21 | 1999-07-13 | Warner-Lambert Company | Butenolide endothelin antagonists |
| AU6603996A (en) * | 1995-08-24 | 1997-03-19 | Warner-Lambert Company | Furanone endothelin antagonists |
| US5891892A (en) * | 1996-10-29 | 1999-04-06 | Warner-Lambert Company | Small molecule biaryl compounds as inhibitors of endothelin converting enzyme |
| DE60234057D1 (de) | 2001-07-25 | 2009-11-26 | Raptor Pharmaceutical Inc | Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke |
| US20110104186A1 (en) | 2004-06-24 | 2011-05-05 | Nicholas Valiante | Small molecule immunopotentiators and assays for their detection |
| EP2392258B1 (en) | 2005-04-28 | 2014-10-08 | Proteus Digital Health, Inc. | Pharma-informatics system |
| US8795627B2 (en) | 2007-03-21 | 2014-08-05 | Raptor Pharmaceuticals Inc. | Treatment of liver disorders by administration of RAP conjugates |
| AU2010216512B2 (en) | 2009-02-20 | 2016-06-30 | 2-Bbb Medicines B.V. | Glutathione-based drug delivery system |
| WO2010129819A2 (en) | 2009-05-06 | 2010-11-11 | Laboratory Skin Care, Inc. | Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same |
| US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
| FR2978963A1 (fr) | 2011-08-11 | 2013-02-15 | Ascorbix | Nouveaux derives des furanones et composition pharmaceutique les contenant |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2359208A (en) * | 1941-03-21 | 1944-09-26 | Lilly Co Eli | beta-substituted-delta alpha,beta-gamma-butyrolactones and beta-substituted-beta-hydroxy-gamma-butyrolactones and the methods of preparing them |
| US2359096A (en) * | 1941-03-21 | 1944-09-26 | Lilly Co Eli | beta-substituted-delta alpha, beta-gamma-butyrolactones and beta-substituted - beta - hydroxy-gamma-butyrolactones and methods of preparing them |
| DE3472958D1 (en) * | 1983-08-03 | 1988-09-01 | Univ California | Synthetic analgesic and/or anti-inflammatory derivatives of manoalide |
| US4447445A (en) * | 1983-08-03 | 1984-05-08 | The Regents Of The University Of Calif. | Manoalide, an anti-inflammatory analgesic marine natural product |
| US4789749A (en) * | 1984-06-18 | 1988-12-06 | The Regents Of The University Of California | Manoalide analogs |
| ZA864674B (en) * | 1985-07-01 | 1988-02-24 | Lilly Co Eli | Furanone derivatives |
| US4874782A (en) * | 1985-07-01 | 1989-10-17 | Eli Lilly And Company | Furanone derivatives |
| US4786651A (en) * | 1986-02-03 | 1988-11-22 | Allergan, Inc. | Treatment of cutaneous hyperproliferative dermatoses with manoalide |
| DE3615157A1 (de) * | 1986-05-05 | 1987-11-12 | Schwabe Willmar Gmbh & Co | 5-arylalkyl-4-alkoxy-2(5h)-furanone, zwischenprodukte und verfahren zu ihrer herstellung sowie ihre anwendung als therapeutische wirkstoffe |
| US5059611A (en) * | 1988-11-18 | 1991-10-22 | Allergan, Inc. | Anti-inflammatory 5-hydroxy-2-furanones |
| CA1329390C (en) * | 1987-06-08 | 1994-05-10 | John N. Bonfiglio | Anti-inflammatory furanones |
| US5089485A (en) * | 1988-11-18 | 1992-02-18 | Allergan, Inc. | Anti-inflammatory furanones |
| US5037811A (en) * | 1990-04-17 | 1991-08-06 | Allergan, Inc. | 4-(oxygen, sulfur or nitrogen substituted)-methyl 5-hydroxy-2(5H)-furanones as anti-inflammatory agents |
| US5043457A (en) * | 1990-04-17 | 1991-08-27 | Allergan, Inc. | 2(5H)-furanones substituted in the 3 position, as Ca2+ channel antagonists and anti-inflammatory agents |
| US4916241A (en) * | 1988-06-06 | 1990-04-10 | American Home Products Corporation | Inhibition of bone loss by 4-substituted-5-hydroxy-2(5H)-furanones |
| JPH0222271A (ja) * | 1988-07-11 | 1990-01-25 | Kuraray Co Ltd | 共役γ−オキシブテノライド化合物およびこれを有効成分とする抗潰瘍剤 |
| US4935530A (en) * | 1988-10-18 | 1990-06-19 | Allergan, Inc. | Process for preparing 5-substituted-3-furaldehydes |
| EP0369813A3 (en) * | 1988-11-18 | 1991-02-27 | Allergan, Inc | Anti-inflammatory furanones |
| EP0372941A3 (en) * | 1988-12-07 | 1991-02-06 | Allergan, Inc | Anti-inflammatory 5-hydroxy-2-furanones |
| US5045564A (en) * | 1988-12-07 | 1991-09-03 | Allergan, Inc. | Anti-inflammatory 2-furanones |
| US5013850A (en) * | 1990-03-30 | 1991-05-07 | Allergan, Inc. | 4-ethyl and 4-ethenyl-5-hydroxy-2(5H)-furanones substituted on alpha carbon of the ethyl or ethenyl side chain with a long chain alkyl group and on the beta carbon with a polar group, as anti-inflammatory agents |
-
1991
- 1991-04-30 US US07/693,204 patent/US5183906A/en not_active Expired - Lifetime
-
1992
- 1992-04-29 ES ES92911576T patent/ES2124261T3/es not_active Expired - Lifetime
- 1992-04-29 WO PCT/US1992/003623 patent/WO1992019610A1/en active IP Right Grant
- 1992-04-29 AU AU19238/92A patent/AU1923892A/en not_active Abandoned
- 1992-04-29 DE DE69227366T patent/DE69227366T2/de not_active Expired - Fee Related
- 1992-04-29 CA CA002109064A patent/CA2109064A1/en not_active Abandoned
- 1992-04-29 JP JP51148292A patent/JP3181054B2/ja not_active Expired - Fee Related
- 1992-04-29 EP EP92911576A patent/EP0579769B1/en not_active Expired - Lifetime
- 1992-04-29 AT AT92911576T patent/ATE172459T1/de not_active IP Right Cessation
-
1993
- 1993-10-29 NO NO933918A patent/NO933918L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO933918L (no) | 1993-12-28 |
| EP0579769A1 (en) | 1994-01-26 |
| ES2124261T3 (es) | 1999-02-01 |
| ATE172459T1 (de) | 1998-11-15 |
| US5183906A (en) | 1993-02-02 |
| EP0579769B1 (en) | 1998-10-21 |
| JP3181054B2 (ja) | 2001-07-03 |
| AU1923892A (en) | 1992-12-21 |
| DE69227366T2 (de) | 1999-06-10 |
| WO1992019610A1 (en) | 1992-11-12 |
| DE69227366D1 (de) | 1998-11-26 |
| CA2109064A1 (en) | 1992-10-31 |
| JPH06507171A (ja) | 1994-08-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO933918D0 (no) | 2- og 5-alkyl- og fenylsubstituerte 4-(1-hydroksy-, 1-acyloksy- eller 1-karbamoyloksy)-5-hydroksy-2(5h)-furanoner som anti-inflammatoriske midler | |
| AU653057B2 (en) | Cosmetic composition | |
| ES527954A1 (es) | Un procedimiento para preparar isoxazoles | |
| AU585452B2 (en) | Oxiranes | |
| BR8707408A (pt) | Novos 5-alcoxi-2,4-diamino-alquibenzenos e composicoes de tingimento de cabelo com 5-alcoxi-2,4-diamino-alquil-benzenos | |
| IE830785L (en) | Pharmaceutical compositions containing oxicam derivatives | |
| DE69725708D1 (de) | Neue poly(monoperoxycarbanate) | |
| ATE165972T1 (de) | 2(5h)- in position 3-substituierte furanone als ca 2+ antagonisten und entzündungshemmende mittel | |
| KR890014443A (ko) | 신규한 치환 나프타렌 화합물 및 동 화합물을 함유하는 액정조성물 | |
| AU533417B2 (en) | Mixtures of stilbene optical brighteners | |
| DK0460488T3 (da) | Svovlholdige heterocykliske forbindelser | |
| ES2074828T3 (es) | Copoliester degradable de 4-hidroxi-prolina y composicion farmaceutica que lo contiene. | |
| KR920007947A (ko) | 살균성 바이오세라믹 조성물 | |
| MX170732B (es) | Composicion de derivados de succinimida y su uso | |
| FI892681A (fi) | Nya jodade icke-joniska trijodbenzenfoereningar och dessa innehaollande kontrastmedel. | |
| IE830469L (en) | Fungicidal cyanopropenoates | |
| GB2020656A (en) | Tricyclo- alpha , beta -unsaturated ketones | |
| ES8705426A1 (es) | Un procedimiento para la preparacion de un derivado de piperazina. | |
| FI812777L (fi) | Foerfarande foer framstaellning av nya cardenolid-bis-digitoxosider | |
| JPS53127450A (en) | 3-alkoxy-4-homoisotwistanes, their preparation and perfume compositions containing the same | |
| AU7663881A (en) | 3-oxabicyclo(3.1.0)hexan-2-ones | |
| KR920002755A (ko) | 안정화된 과탄산나트륨 조성물 | |
| JPS56142228A (en) | Manufacture of chlorophenols | |
| FI865121A (fi) | Foerfarande foer genomfoerande av magnetiska kretsar foer stabiliseringsspolar till anvaendning i en kombination av lampor med olika urladdning. | |
| KR830000766A (ko) | 폴리글리콜 에테르를 함유한 섬유조제물 |